Logo image of CON

CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

NYSE:CON - New York Stock Exchange, Inc. - US20603L1026 - Common Stock - Currency: USD

21.91  -0.63 (-2.8%)

Fundamental Rating

5

Taking everything into account, CON scores 5 out of 10 in our fundamental rating. CON was compared to 102 industry peers in the Health Care Providers & Services industry. CON has an average financial health and profitability rating. CON has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CON had positive earnings in the past year.
CON had a positive operating cash flow in the past year.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

CON has a Return On Assets of 6.61%. This is amongst the best in the industry. CON outperforms 85.29% of its industry peers.
With an excellent Return On Equity value of 60.41%, CON belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.13%, CON belongs to the top of the industry, outperforming 87.25% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CON is significantly above the industry average of 9.53%.
The last Return On Invested Capital (12.13%) for CON is well below the 3 year average (23.70%), which needs to be investigated, but indicates that CON had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.61%
ROE 60.41%
ROIC 12.13%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

CON has a Profit Margin of 8.76%. This is amongst the best in the industry. CON outperforms 91.18% of its industry peers.
In the last couple of years the Profit Margin of CON has declined.
CON has a better Operating Margin (16.13%) than 91.18% of its industry peers.
CON's Operating Margin has declined in the last couple of years.
CON's Gross Margin of 27.79% is in line compared to the rest of the industry. CON outperforms 52.94% of its industry peers.
CON's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.13%
PM (TTM) 8.76%
GM 27.79%
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

CON has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CON has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CON has a worse debt to assets ratio.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.00 indicates that CON is not a great score, but indicates only limited risk for bankruptcy at the moment.
CON has a Altman-Z score (2.00) which is in line with its industry peers.
The Debt to FCF ratio of CON is 3.05, which is a good value as it means it would take CON, 3.05 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.05, CON is doing good in the industry, outperforming 77.45% of the companies in the same industry.
A Debt/Equity ratio of 5.33 is on the high side and indicates that CON has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 5.33, CON is doing worse than 82.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.33
Debt/FCF 3.05
Altman-Z 2
ROIC/WACC1.5
WACC8.09%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B

2.3 Liquidity

CON has a Current Ratio of 1.42. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
CON has a Current ratio (1.42) which is comparable to the rest of the industry.
A Quick Ratio of 1.42 indicates that CON should not have too much problems paying its short term obligations.
CON has a Quick ratio of 1.42. This is comparable to the rest of the industry: CON outperforms 53.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.72% over the past year.
Measured over the past years, CON shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.99% on average per year.
The Revenue has been growing slightly by 3.38% in the past year.
CON shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.14% yearly.
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-28.41%
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%-74.7%

3.2 Future

The Earnings Per Share is expected to grow by 8.29% on average over the next years. This is quite good.
CON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.50% yearly.
EPS Next Y-4.81%
EPS Next 2Y6.02%
EPS Next 3Y8.29%
EPS Next 5YN/A
Revenue Next Year11.88%
Revenue Next 2Y9.62%
Revenue Next 3Y8.5%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.65 indicates a reasonable valuation of CON.
Based on the Price/Earnings ratio, CON is valued cheaper than 93.14% of the companies in the same industry.
CON's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.60.
Based on the Price/Forward Earnings ratio of 16.35, the valuation of CON can be described as correct.
69.61% of the companies in the same industry are more expensive than CON, based on the Price/Forward Earnings ratio.
CON is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.65
Fwd PE 16.35
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CON is valued a bit cheaper than the industry average as 65.69% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CON indicates a rather cheap valuation: CON is cheaper than 93.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.79
EV/EBITDA 11.2
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

CON has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.02%
EPS Next 3Y8.29%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.10%, CON has a reasonable but not impressive dividend return.
CON's Dividend Yield is rather good when compared to the industry average which is at 2.46. CON pays more dividend than 84.31% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CON's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

CON does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

CON pays out 4.78% of its income as dividend. This is a sustainable payout ratio.
DP4.78%
EPS Next 2Y6.02%
EPS Next 3Y8.29%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 100M 200M 300M 400M 500M
CON Dividend Payout.CON Dividend Payout, showing the Payout Ratio.CON Dividend Payout.PayoutRetained Earnings

More info and screens

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (5/21/2025, 3:24:08 PM)

21.91

-0.63 (-2.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-28 2025-07-28
Inst Owners85.81%
Inst Owner Change-0.4%
Ins Owners6.63%
Ins Owner Change-1445.28%
Market Cap2.81B
Analysts81.67
Price Target28.12 (28.34%)
Short Float %1.85%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.78%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-20 2025-05-20 (0.0625)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.22%
Min EPS beat(2)1.24%
Max EPS beat(2)3.19%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.18%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-0.78%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.72%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)2.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)4.17%
Valuation
Industry RankSector Rank
PE 9.65
Fwd PE 16.35
P/S 1.48
P/FCF 5.79
P/OCF 5.11
P/B 10.19
P/tB N/A
EV/EBITDA 11.2
EPS(TTM)2.27
EY10.36%
EPS(NY)1.34
Fwd EY6.12%
FCF(TTM)3.78
FCFY17.27%
OCF(TTM)4.29
OCFY19.56%
SpS14.83
BVpS2.15
TBVpS-9.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.61%
ROE 60.41%
ROCE 13.84%
ROIC 12.13%
ROICexc 13.22%
ROICexgc 45.4%
OM 16.13%
PM (TTM) 8.76%
GM 27.79%
FCFM 25.53%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
ROICexc(3y)24.7%
ROICexc(5y)N/A
ROICexgc(3y)89.31%
ROICexgc(5y)N/A
ROCE(3y)27.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 5.33
Debt/FCF 3.05
Debt/EBITDA 3.93
Cap/Depr 95.76%
Cap/Sales 3.39%
Interest Coverage 6.17
Cash Conversion 147.04%
Profit Quality 291.23%
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 2
F-Score5
WACC8.09%
ROIC/WACC1.5
Cap/Depr(3y)84.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)N/A
Profit Quality(3y)135.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-28.41%
EPS Next Y-4.81%
EPS Next 2Y6.02%
EPS Next 3Y8.29%
EPS Next 5YN/A
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%-74.7%
Revenue Next Year11.88%
Revenue Next 2Y9.62%
Revenue Next 3Y8.5%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3Y-0.08%
EBIT growth 5YN/A
EBIT Next Year36.67%
EBIT Next 3Y17.63%
EBIT Next 5YN/A
FCF growth 1Y21.47%
FCF growth 3Y-3.19%
FCF growth 5YN/A
OCF growth 1Y17.23%
OCF growth 3Y-1.87%
OCF growth 5YN/A